Ocupharm diagnostic S.L

Company specialized in assistance and help with the research, development and regulation of ophthalmological products.

 Experience of the “Ocupharm Diagnostics”

Ocupharm Diagnostics has participated in different Autonomous/State financing projects for industrial doctorates. In addition, being part of consortia of European projects of the Horizon2020 program, highlighting:

  • Neonet 3D. Proyecto RISE. (2016-2020)
  • Orbital. Proyecto ETN. (2019-2023)
  • Cristal. Proyecto RISE (2020-2024)
  • DRY-EYE. Proyecto financiación Europea SME (2015-2016)

Ocupharm Diagnostics S.L has provided services to leading pharmaceutical and healthcare companies in their sector, providing advice, design and execution of research projects, regulatory support and innovation.

Our integral participation in the design of the studies provides robustness and scientific consolidation to the studies that serve as a basis to comply with legal requirements (MD 2017/745 and MD 2017/746).

The main strength of the company is adaptability, based on extensive knowledge of the ophthalmological sector, which allows us full flexibility and total customization of studies to comply with legal requirements and client expectations.